Your last physical almost certainly checked your glucose. It almost certainly did not check the hormone working overtime to keep that glucose looking normal.
That’s the whole problem with screening for metabolic disease by glucose alone: glucose is the number that fails last. In the Whitehall II study, which followed thousands of adults for years before they developed type 2 diabetes, fasting glucose stayed close to normal until roughly three years before diagnosis — while insulin sensitivity had been deteriorating for more than a decade. The disease process was measurable the entire time. Just not in the number the physical looks at.
Fasting insulin is where that process shows up early. It is a cheap, ordinary blood test, and it is almost never on a standard panel.
What fasting insulin actually measures
Insulin is the hormone your pancreas releases to move glucose out of the blood and into cells. A fasting insulin level — drawn in the morning, before food — measures how much insulin it takes to hold your glucose steady when nothing else is going on.
That framing matters. Two people can have an identical fasting glucose of 90 mg/dL, and be in completely different metabolic situations: one holding that 90 with a whisper of insulin, the other holding it with five times as much. The second person’s cells have stopped listening — insulin resistance — and the pancreas is compensating by shouting. Glucose looks fine because insulin is high. The compensation is the disease process; the normal glucose is the disguise.
Why glucose alone misses it
Insulin resistance can progress for ten to fifteen years behind a normal glucose, because a healthy pancreas is very good at compensating. Only when the beta cells begin to fail does glucose finally drift up into the prediabetes range — at which point the underlying problem is old. This is exactly what the trajectory studies show, and it’s why researchers who re-analyzed Joseph Kraft’s large insulin-response database found abnormal insulin patterns in a majority of people whose glucose tolerance was, by the standard criteria, perfectly normal.
A related shorthand you’ll see on lab reviews is HOMA-IR — a formula (fasting glucose × fasting insulin ÷ 405, in US units) that estimates insulin resistance from the two fasting values. It’s useful and we report it, with honest limits: it’s an approximation derived for population research, not a diagnosis; it inherits the assay variability of the insulin test; and it says nothing a thoughtful read of insulin, glucose, and triglycerides together doesn’t already say. Values under about 1.0 generally indicate good insulin sensitivity; values above roughly 2.5 suggest meaningful resistance, with cutoffs varying by population and lab.
What’s an optimal fasting insulin level?
Here the gap between “lab normal” and “optimal” is wider than for almost any other marker on a panel. Many lab reference ranges run from roughly 2.6 up to 24.9 µIU/mL — meaning a value of 20, which most preventive clinicians would consider unambiguous hyperinsulinemia, can print without a flag.
| Fasting insulin (µIU/mL) | How to read it |
|---|---|
| < 6 | The range many preventive clinicians treat as the goal in the presence of normal glucose; typical of insulin-sensitive adults |
| 6–9 | Commonly cited as broadly optimal (< 8 is the most-quoted threshold); the upper edge is where early resistance starts to appear in research cohorts |
| 10–14 | Usually inside the lab’s “normal” — but for most adults, consistent with real insulin resistance, especially alongside rising triglycerides or waist size |
| 15–24 | Hyperinsulinemia by most clinical definitions, frequently still unflagged by the printed range; warrants a clinician conversation |
| ≥ 25 | Above even permissive lab ranges; clearly elevated |
Three honest caveats. First, insulin assays are imperfectly standardized between laboratories — a documented problem the ADA has convened working groups on — so your number should be interpreted against the reporting lab’s method, and trends should be tracked on the same assay. Second, check your units: most US labs report µIU/mL (identical to mIU/L), while some report pmol/L, which runs several-fold higher — a 40 that alarms you may be a perfectly ordinary 6. Third, low is only good news next to a normal glucose. A low insulin with a high glucose means the pancreas is no longer keeping up — a later and more serious stage, and one more reason this number should be read by a physician, in context, not eyeballed against a table.
High fasting insulin has no symptoms
None you can attribute to it, anyway. Chronically elevated insulin does not announce itself; it works quietly for years — driving fat storage, pushing triglycerides up, nudging blood pressure, stimulating the liver’s output of atherogenic particles — while you feel essentially fine. By the time metabolic disease produces symptoms you’d take to a doctor, the insulin story is typically a decade old. The only way to know where you are in that story is to measure it.
What drives fasting insulin up
- Energy surplus and visceral fat. Fat stored around the organs is the strongest everyday driver of insulin resistance; the waistline and this number tend to travel together.
- Muscle that isn’t used. Skeletal muscle is the body’s largest glucose sink. Inactivity shrinks the sink; resistance training and regular movement enlarge it.
- Sleep debt and chronic stress. Even short-term sleep restriction measurably worsens insulin sensitivity; cortisol works against insulin directly.
- Genetics and conditions. Family history of type 2 diabetes, polycystic ovary syndrome, and some ancestry-linked risk patterns raise baseline insulin independent of lifestyle.
- Some medications — corticosteroids and certain antipsychotics among them — push insulin and glucose in the wrong direction.
Can you lower it?
Yes — fasting insulin is among the most responsive numbers on a comprehensive panel, which is precisely what makes it worth tracking. Insulin sensitivity improves with weight loss (visceral fat especially), resistance and aerobic exercise, sleep repair, and dietary changes a clinician can tailor — and the number moves on a timescale of weeks to months, fast enough to confirm that what you’re doing is working. Where a clinician judges it appropriate, medications that improve insulin sensitivity enter the conversation. What matters for this page: every one of those decisions starts with knowing the number, and progress is confirmed by retesting it.
Terve Health measures and tracks fasting insulin and its context; treatment decisions are always made with a licensed clinician.
How to get your fasting insulin tested
Three realistic routes:
- Ask at your physical. Your doctor can add fasting insulin to your labs. Many will if asked — it simply isn’t part of the default screening panel, and insurance coverage for it as a screening test is inconsistent.
- Order it a la carte. Direct-to-consumer single tests typically run $10–40. But a lone insulin value without glucose, HbA1c, triglycerides, and liver markers like ALT around it is a sentence ripped out of a paragraph — and nobody reviews it with you.
- Measure it inside a full panel that a physician actually reads. Terve Health is a whole-body panel, drawn fasting at any of 2,000+ Quest locations, ordered by a licensed clinician at our medical practice, and returned as a written plain-language review — your insulin next to your glucose, A1c, lipids, and inflammation markers, what the pattern means, and what to do about it. And if a result turns out to need real medical follow-up, the practice behind your panel delivers actual care — you’re never handed a worrying number and told to go find a doctor.
Fasting insulin and the rest of the picture
Fasting insulin is most powerful in context:
- HbA1c and fasting glucose — the lagging indicators. High insulin with a still-normal A1c is the compensation phase: the most valuable moment to find the problem, because everything is still reversible.
- Triglycerides & HDL — the metabolic signature. A rising triglyceride-to-HDL ratio is the classic companion of insulin resistance, and often the first lipid clue.
- ApoB — the crossover to heart risk. An insulin-resistant liver exports more atherogenic particles, often while standard cholesterol looks ordinary; this is exactly why we read the two together.
- Ferritin — an unexpectedly metabolic marker. Moderately elevated ferritin frequently travels with insulin resistance rather than iron overload.
- Uric acid — high insulin makes the kidneys hold on to urate, so the two often rise together years before glucose moves — an early metabolic pattern when read as a pair.
Browse the full biomarker library to see everything the panel covers.
Frequently asked questions
What is a good fasting insulin level? Lab ranges commonly extend to ~25 µIU/mL, but most preventive clinicians consider under 8 desirable and many aim for under 6 alongside normal glucose. There is no single agreed cutoff — assays vary, and the value should be read with your glucose, A1c, and triglycerides, which is what a physician review is for.
What does high fasting insulin with normal glucose mean? Usually that your pancreas is successfully compensating for insulin resistance — glucose looks fine because insulin is elevated. It’s the earliest measurable stage of the process that can end in type 2 diabetes, and the stage at which lifestyle changes work best.
Do I need to fast for an insulin test? Yes — insulin responds strongly to food, so a non-fasting value is largely uninterpretable against fasting ranges. Standard practice is a morning draw after 8–12 hours without calories. Terve Health draws are morning, fasting.
Fasting insulin vs. HbA1c — which is better? They answer different questions. A1c summarizes average glucose over ~3 months — it tells you whether compensation has already failed. Fasting insulin tells you how hard your body is working to keep glucose normal — it moves years earlier. On a comprehensive panel you don’t choose; you read them together.
How do you lower fasting insulin? Insulin sensitivity responds to weight loss, resistance and aerobic exercise, better sleep, and dietary changes — and the number falls fast enough to verify progress within months. The right plan depends on your full picture, which is a conversation for a licensed clinician who has actually seen your results.
Sources
- Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: the Whitehall II study. Lancet. 2009.
- Matthews DR, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985.
- Crofts C, et al. Identifying hyperinsulinaemia in the absence of impaired glucose tolerance: an examination of the Kraft database. Diabetes Research and Clinical Practice. 2016.
- DiNicolantonio JJ, et al. Postprandial insulin assay as the earliest biomarker for diagnosing pre-diabetes, type 2 diabetes and increased cardiovascular risk. Open Heart. 2017.
- Staten MA, et al. Insulin assay standardization. Diabetes Care. 2010.
- American Diabetes Association. Standards of Care in Diabetes. 2025. (Glycemic category definitions for context.)
Terve Health measures and helps you understand your biomarkers; it does not diagnose, treat, or prevent disease. Laboratory testing performed by Quest Diagnostics®; testing is ordered and results are reviewed by licensed clinicians at an independent medical practice. Always discuss results and treatment with a licensed clinician.